- Home
- HSCS vs BGLC Comparison
HSCS vs BGLC Comparison
Compare HSCS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- BGLC
- Stock Information
- Founded
- HSCS 2007
- BGLC 2017
- Country
- HSCS United States
- BGLC Malaysia
- Employees
- HSCS N/A
- BGLC N/A
- Industry
- HSCS Medical Specialities
- BGLC Medical Specialities
- Sector
- HSCS Health Care
- BGLC Health Care
- Exchange
- HSCS Nasdaq
- BGLC Nasdaq
- Market Cap
- HSCS 8.7M
- BGLC 10.4M
- IPO Year
- HSCS 2022
- BGLC N/A
- Fundamental
- Price
- HSCS $3.33
- BGLC $5.04
- Analyst Decision
- HSCS Strong Buy
- BGLC
- Analyst Count
- HSCS 2
- BGLC 0
- Target Price
- HSCS $13.00
- BGLC N/A
- AVG Volume (30 Days)
- HSCS 80.2K
- BGLC 54.1K
- Earning Date
- HSCS 09-09-2025
- BGLC 08-18-2025
- Dividend Yield
- HSCS N/A
- BGLC N/A
- EPS Growth
- HSCS N/A
- BGLC N/A
- EPS
- HSCS N/A
- BGLC N/A
- Revenue
- HSCS $4,350.00
- BGLC $9,551,559.00
- Revenue This Year
- HSCS $13,968.97
- BGLC N/A
- Revenue Next Year
- HSCS $166.67
- BGLC N/A
- P/E Ratio
- HSCS N/A
- BGLC N/A
- Revenue Growth
- HSCS N/A
- BGLC 4.01
- 52 Week Low
- HSCS $2.36
- BGLC $2.01
- 52 Week High
- HSCS $6.47
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- HSCS 43.80
- BGLC 42.79
- Support Level
- HSCS $3.24
- BGLC $5.45
- Resistance Level
- HSCS $3.59
- BGLC $5.79
- Average True Range (ATR)
- HSCS 0.23
- BGLC 0.21
- MACD
- HSCS -0.01
- BGLC -0.06
- Stochastic Oscillator
- HSCS 13.04
- BGLC 4.94
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.